Quarterly Transactions Made in Avadel Pharmaceuticals PLC (AVDL)
This table provides information about the institutional ownership of Avadel Pharmaceuticals PLC (AVDL). The information is specifically focused on institutions that hold shares of AVADEL PHARMACEUTICALS PLC.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 2,439,786 | 1,334,745 | 3,774,531 | 2,799,135 | 232,180 | 3,031,315 | 743,216 | |
| Q4 2021 | 2,922,845 | 2,860,906 | 5,783,751 | 2,155,371 | 368,828 | 2,524,199 | 3,259,552 | |
| Q1 2022 | 2,037,685 | 1,541,912 | 3,579,597 | 741,853 | 2,033,307 | 2,775,160 | 804,437 | |
| Q2 2022 | 2,895,820 | 1,865,031 | 4,760,851 | 2,062,208 | 5,068,645 | 7,130,853 | -2,370,002 | |
| Q3 2022 | 1,401,631 | 328,785 | 1,730,416 | 3,639,378 | 0 | 3,639,378 | -1,908,962 | |
| Q4 2022 | 1,387,498 | 3,156,731 | 4,544,229 | 1,894,279 | 17,000 | 1,911,279 | 2,632,950 | |
| Q1 2023 | 12,623,505 | 4,504,131 | 17,127,636 | 874,145 | 12,000 | 886,145 | 16,241,491 | |
| Q2 2023 | 4,291,551 | 6,120,470 | 10,412,021 | 3,708,246 | 0 | 3,708,246 | 6,703,775 | |
| Q3 2023 | 5,325,061 | 506,022 | 5,831,083 | 2,865,963 | 0 | 2,865,963 | 2,965,120 | |
| Q4 2023 | 4,300,577 | 6,111,039 | 10,411,616 | 3,392,580 | 0 | 3,392,580 | 7,019,036 | |
| Q1 2024 | 9,915,897 | 8,406,475 | 18,322,372 | 2,636,635 | 0 | 2,636,635 | 15,685,737 | |
| Q2 2024 | 7 | 10,055 | 10,062 | 87,907 | 0 | 87,907 | -77,845 | |
| Q3 2024 | — | 1,000 | 0 | 1,000 | -1,000 | |||